AstraZeneca

Educational links

The following health information sites provide general information about asthma that your patients, their families, and your staff may find useful.

Professional societies

Patient education and support

Note: These Web sites are external to AstraZeneca. AstraZeneca does not possess editorial control of their content and no endorsement, expressed or implied, is intended.

Professional societies

American Academy of Allergy, Asthma & Immunology
555 East Wells Street
Suite 1100
Milwaukee, WI 53202-3823
www.aaaai.org

American Academy of Pediatrics
141 Northwest Point Boulevard
Elk Grove Village, IL 60007-1098
www.aap.org

American College of Allergy, Asthma & Immunology
85 West Algonquin Road, Suite 550
Arlington Heights, IL 60005
www.acaai.org

National Heart, Lung, and Blood Institute
10 Center Drive, MSC-1668
Bethesda, MD 20892-1668
www.nhlbi.org

Patient education and support

Allergy and Asthma Network Mothers of Asthmatics, Inc.
2751 Prosperity Avenue, Suite 150
Fairfax, VA 22031
www.aanma.org

The American Lung Association
1740 Broadway
NY, NY 10019
www.lungusa.org

Asthma and Allergy Foundation of America
1233 20th Street, NW
Suite 402
Washington, DC 20036
www.aafa.org

Beansprout Networks
Ten Wilson Road
Cambridge, MA 02138
www.beansprout.net

The Consortium on Children's Asthma Camps
490 Concordia Avenue
St. Paul, MN 55103-2441
www.asthmacamps.org

National Jewish Medical and Research Center
1400 Jackson Street
Denver, CO 80206
www.njc.org

Indication and Important Safety Information

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.

PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of acute bronchospasm.

Common adverse events reported in clinical trials, regardless of relationship to treatment, included respiratory infection, rhinitis, coughing, otitis media, viral infection, gastroenteritis, ear infection, oral thrush/candidiasis, and epistaxis.

Inhaled corticosteroids may cause a reduction in growth velocity. The long-term effect on final adult height is unknown.

PULMICORT RESPULES, like other inhaled corticosteroids, may impact the hypothalamic-pituitary-adrenal axis, especially in susceptible individuals, in young children, and in patients given high doses for prolonged periods.

Particular care is needed for patients who are transferred from systemically active corticosteroids to less systemically available corticosteroids, because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids (see WARNINGS in full Prescribing Information).

Patients taking immunosuppressant doses of corticosteroids should avoid exposure to infections such as chicken pox and measles.

[Please see accompanying full Prescribing Information.]